Home > Healthcare > Medical Devices > Diagnostic Devices > GI Stool Testing Market

GI Stool Testing Market Trends

Report ID: GMI5719
Published Date: May 2023
Report Format: PDF

Download Free Sample

GI Stool Testing Market Trends

The increasing prevalence of gastrointestinal diseases is anticipated to proliferate market expansion. Growing baby boomer generation suffering from gastrointestinal infections have accelerated the demand for diagnostic procedures that has further propelled the market landscape. Gastrointestinal disorders such as digestive tract bleeding, ulcers, chronic pancreatitis, ulcerative colitis (UC), inflammatory bowel disease (IBD), and abnormal growth in the GI tract promote substantial disease burden. These ailments inflict the health care costs and affect the health-associated quality of life. According to the American Gastroenterology Association (AGA) publication 2021, more than 40% of individuals globally suffer from functional gastrointestinal disorders (FGIDs) that include a variety of GI conditions.

Further, rising incidence of chronic diseases including gastrointestinal cancer leads to a large number of patients opting stool test for diagnosis. In the U.S., colorectal cancer (CRC) is the 3rd most commonly diagnosed cancer and the 3rd most common cause of cancer-related death in both men and women. Hence, owing to the above statistics rising prevalence of gastrointestinal disorders is set to increase the demand for diagnostic procedures that will prove beneficial for the business progress.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for GI stool testing was valued at USD 600.1 million in 2022 and will reach over USD 1.2 billion by 2032 propelled by factors including unhealthy lifestyles, rising occurrences of diabetes, and the aging population, among others.

The consumables segment was worth over USD 376 million in 2022 as a result of an increase in the preference for GI disease diagnostic reagents and test kits.

The gastrointestinal infection application segment dominated the market with more than 38% revenue share in 2022 owing to the growing prevalence of GI infection and preference for technologically advanced GI diagnostic tests.

The U.S. GI stool testing market was valued at USD 254 million in 2022 due to the strong presence of major industry players and the rising prevalence of gastrointestinal disorders in the country.